Altimmune
ALT
110 hedge funds and large institutions have $467M invested in Altimmune in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 30 closing their positions.
647% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $1.75M
600% more funds holding in top 10
Funds holding in top 10: 1 → 7 (+6)
125% more capital invested
Capital invested by funds: $207M → $467M (+$260M)
27% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 30
14.47% more ownership
Funds ownership: 77.86% → 92.33% (+14%)
7% more funds holding
Funds holding: 103 → 110 (+7)
13% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 31
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$12.2M |
| 2 |
D.E. Shaw & Co
New York
|
-$4.92M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.43M |
| 4 |
VA
VR Adviser
New York
|
-$2.41M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.82M |
ALT Hedge Fund Activity: Q2 2022 in Review
110 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2022, worth a combined $467M — up 125% from $207M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ALT positions and 30 closed out — a net gain of 8 holders — while 27 added to existing stakes and 31 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $18.5M. The largest seller was BlackRock, cutting an estimated $12.2M.
- 110 institutional investors held Altimmune (ALT) as of Q2 2022, up from 103 in Q1 2022.
- Funds reported $467M of Altimmune stock for Q2 2022, up 125% quarter-over-quarter.
- 38 funds opened new Altimmune positions in Q2 2022 and 30 closed out, a net change of +8 holders.
- The largest Altimmune buyer in Q2 2022 was Cormorant Asset Management, an estimated $18.5M added.
- The largest Altimmune seller in Q2 2022 was BlackRock, an estimated $12.2M sold.
Based on aggregated 13F filings for Q2 2022.